Table 5. Resistance to anti-tuberculosis drugs according to pulmonary/extrapulmonary tuberculosis and tuberculosis treatment history.
Values are presented as number (%).
PTB, pulmonary tuberculosis; EPTB, extrapulmonary tuberculosis; MDR, multidrug-resistance; XDR, extensively drug-resistance; PAS, para-aminosalicylic acid.
aPTB included relapse (n = 237), TAI (n = 47), and TAF (n = 12).
bEPTB included relapse (n = 17) and TAI (n = 1).
cAmikacin sensitivity testing was performed in 1,575 cases, including 1,455 new cases and 120 previously treated cases.
dLevofloxacin sensitivity testing was performed in 1,357 cases, including 1,259 new cases and 99 previously treated cases.